Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Median progression-free survival was 13.1 and 8.7 months with pembrolizumab and placebo, respectively, in the pMMR cohort (hazard ratio, 0.54).